First US drug approved for a liver disease surging around the world
Briefly

"It's a huge population," says Na Li, a hepatologist at Ohio State University Wexner Medical Center in Columbus. "And I think we have made a big step forward to improve their care."
"Many trials over the years have failed, even those that initially looked promising," says Li. "That's the tragedy we've had."
Read at Nature
[
add
]
[
|
|
]